Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Payables: 2016-2021

Historic Payables for ENDRA Life Sciences (NDRA) over the last 5 years, with Sep 2021 value amounting to $1.4 million.

  • ENDRA Life Sciences' Payables rose 9.37% to $1.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $4.6 million, marking a year-over-year decrease of 23.77%. This contributed to the annual value of $910,183 for FY2020, which is 54.64% down from last year.
  • As of Q3 2021, ENDRA Life Sciences' Payables stood at $1.4 million, which was down 4.34% from $1.5 million recorded in Q2 2021.
  • In the past 5 years, ENDRA Life Sciences' Payables registered a high of $2.0 million during Q4 2019, and its lowest value of $162,302 during Q2 2017.
  • Moreover, its 3-year median value for Payables was $1.4 million (2019), whereas its average is $1.3 million.
  • Its Payables has fluctuated over the past 5 years, first spiked by 362.95% in 2018, then plummeted by 54.64% in 2020.
  • ENDRA Life Sciences' Payables (Quarterly) stood at $848,214 in 2017, then grew by 14.90% to $974,583 in 2018, then skyrocketed by 105.89% to $2.0 million in 2019, then plummeted by 54.64% to $910,183 in 2020, then rose by 9.37% to $1.4 million in 2021.
  • Its Payables was $1.4 million in Q3 2021, compared to $1.5 million in Q2 2021 and $686,650 in Q1 2021.